January 8, 2024 by Peter Matz
director of Food, Health care outlook 2024: Peter Matz, Pharmacy and Health Policy at FMI – The Food Industry Association
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Up until a few years ago, when meeting with lawmakers to advocate for pharmacy benefit manager reform measures, we typically
January 8, 2024 by Michael Hogue
APhA, CEO, Michael Hogue
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. As the oldest national professional association for pharmacists, pharmacy technicians, student pharmacists and pharmaceutical scientists, the American Pharmacists Association touches
January 8, 2024 by Susan Cantrell
AMCP, CEO, Susan Cantrell
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review As we embark on a new year, there is value in taking a moment to reflect on the current state
December 11, 2023 by Todd Huseby, Mike Piccarreta and DJ McKerr
The shifting profit pie: How earnings across the pharma sector
December 11, 2023, Pharmacy
How is the pharmaceutical value chain faring financially? Who are the biggest winners and losers? Every two years, Kearney analyzes pharmaceutical profit pools to answer those questions. Our analysis follows a drug across the value chain, from concept to patient. We aim to understand the profitability of key players in the U.S. value chain and
December 11, 2023 by Chain Drug Review
Special section celebrates NACDS' 90th anniversary
December 11, 2023, Featured Articles, Leading Headlines
Read the December 11th issue of Chain Drug Review, which includes a special section commemorating the 90th anniversary of the founding of the National Association of Chain Drug Stores. The 56-page section is presented by CDR, Drug Store News and the Emerson Group. Here is the link for the issue: http://digitaledition.chaindrugreview.com/publication/?i=809929. The section begins on page
December 11, 2023 by Jeffrey Woldt
An Rx for an ailing health care system
December 11, 2023, Opinion
As the start of a new year approaches, long-standing trends are raising the stakes for big pharmacy operators and other companies with the ambition to re-engineer a health care system plagued by chronic issues of access, quality and cost. With economic and labor challenges continuing to mount, new paradigms for delivering patient care and remunerating
December 11, 2023 by David Pinto
Don’t be late to celebrate NACDS’ 90th anniversary
December 11, 2023, Opinion
This is an especially special holiday season for participants in and advocates of chain drug retailing in America. Reason? The season celebrates and pauses to recall the 90th anniversary of the National Association of Chain Drug Stores. Much has been written over the years, in this publication and others, lauding the indispensable impact NACDS has
December 8, 2023 by Chain Drug Review
Dr. Reddy’s Balasubramanian on growth engines
December 11, 2023, Pharmacy
Dinakaran (Dina) Balasubramanian, head of commercial strategy and insights for biologics at Dr. Reddy’s Laboratories, spoke with Chain Drug Review about his role at the drug maker and how specialty generic drugs and biosimilars are fueling growth for it. CDR: What are your responsibilities now with Dr. Reddy’s Laboratories? BALASUBRAMANIAN: One of my primary responsibilities
November 20, 2023 by Laura Bowen, Dominique Harris, Rodey Wing and Karen Yocky
Efficiency and health equity can align powerfully
Leading Headlines, November 20, 2023
With growing disparities in health outcomes, health care leaders know that it’s important to continue working toward new solutions to improve health equity. But amid ongoing cost pressures and continued labor shortages, addressing health equity can get lost along the way. So, how do we ensure health equity remains a central priority for pharmacy retailers?
November 20, 2023 by Andy Szczotka
Andy Szczotka is chief pharmacy officer of AscellaHealth., Pipeline Digest meets specialty drug market needs
November 20, 2023, Pharmacy
When AscellaHealth released its Q3 2023 Specialty & Rare Pipeline Digest, an expert resource for FDA approval status of specialty pharmaceuticals and cell and gene therapies (CGT), this complimentary, digital source of industry information elevated support for the specialty drug market needs of all stakeholders and decision makers, including pharmaceutical manufacturers, payers, providers and retail
November 20, 2023 by Joel Wayment
Joel Wayment is vice president of operations at Cardinal Health Third Party Logistics., Shared-resource model keeps supply chain flowing
November 20, 2023, Pharmacy
It’s no secret that the supply chain still faces challenges stemming from the COVID-19 pandemic. Even with the public health emergency declared over in May, some supply chain disruptions persist. Thankfully, improved pharmaceutical distribution and transportation solutions can lessen that burden. Across the pharmaceutical industry the goal has been to reduce costs, improve efficiency and
November 20, 2023 by Susie Opare-Abetia
Why drug chains are perfect candidates for RMNs
November 20, 2023, Retail News, Technology
Retail media networks (RMNs) continue to grow at an impressive pace, led by juggernaut Amazon commanding 75% of this industry estimated at over $45 billion for 2023, with Walmart a distant second with less than 8% share. We see this growth across mass retail, grocery, DIY and chain drug with a list that also includes
November 20, 2023 by Samm Anderegg
Samm Anderegg is chief executive officer of DocStation.
November 20, 2023, Pharmacy
It’s no secret that pharmacies and the health care professionals that staff them are under extreme pressure. Pharmacies face a daily challenge in keeping up with prescription demand, as they contend with shrinking profits and a diminishing number of staff willing to endure the demanding workload. Pharmacies are caught in a frustrating race, tirelessly running
November 20, 2023 by Chain Drug Review
especially for acne driving skin care market, Panel: Facial products
Leading Headlines, November 20, 2023, Retail News
AUSTIN, Texas — The $16.8 billion skin care category is one of the fastest-growing across the beauty industry, according to exclusive data presented by Circana at the third annual Dermatology and Retail Alliance. Facial skin care drives sales in the mass market in both dollars and units at a time when gains in many categories